Primary completion· ClinicalTrials.gov
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
sigvotatug vedotin History and Updates
16 events · 2020 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
16
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-08Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for sigvotatug vedotin since 2020, drawn from openFDA, ClinicalTrials.gov, and PubMed.
All published updates (2)
2026
- Primary completionSigvotatug Vedotin Phase 3 for Non-Small Cell Lung Cancer Reaches Primary…· May 18, 2026
- Primary completionSigvotatug Vedotin Phase 3 Trial for NSCLC Reaches Primary Completion· Mar 12, 2026
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-sma
Primary completion· ClinicalTrials.gov
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced
Past events
2026
Primary completion· ClinicalTrials.gov
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Primary completion· ClinicalTrials.gov
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Trial started· ClinicalTrials.gov
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced
2025
Primary completion· ClinicalTrials.gov
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
Trial registered· ClinicalTrials.gov
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced
Trial started· ClinicalTrials.gov
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-sma
Trial registered· ClinicalTrials.gov
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-sma
2024
Trial started· ClinicalTrials.gov
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
Trial registered· ClinicalTrials.gov
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
Trial started· ClinicalTrials.gov
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
2023
Trial registered· ClinicalTrials.gov
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
2020
Trial started· ClinicalTrials.gov
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Trial registered· ClinicalTrials.gov
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.